Basic Information
- Primary DI
- 04049095070167
- Basic UDI-DI Code
- 4049095GN30410000AN
- Reference
- GN3041
- Device Types
-
Single use
- Regulation
- Eu Ivdr
- Classification
- Eu Ivd Class C
- Status
- On The Market
- Manufacturer
- R-Biopharm AG
Additional Description
For in-vitro diagnostics. The RIDAยฎQUICK IFX Monitoring test is a manual immunochromatographic lateral flow test for the quantitative detection of infliximab in human serum and EDTA/citrate plasma samples. The RIDAยฎQUICK IFX Monitoring test is intended to support drug monitoring of infliximab (Remicadeยฎ and its biosimilars Remsimaยฎ, Inflectraยฎ, Flixabiยฎ and Zesslyยฎ) in chronic inflammatory diseases such as spondyloarthritis, rheumatoid arthritis (RA), plaque psoriasis or chronic inflammatory bowel disease (IBD). The test results should not be used as the sole basis for diagnosis. The product is intended for professional use.
CND Nomenclature Codes
| Code | Description |
|---|---|
| W0102080701 | INFLIXIMAB |
Available In Countries
Related Devices
The Basic UDI-DI associated with this device has 2 devices in total. Below are some other devices sharing the same Basic UDI-DI.
Similar Devices
Other on-the-market devices with the same classification (Eu Ivd Class C) and regulation (EU IVDR).